Feedback / Questions
Tremfya (guselkumab) - J&J
Tremfya: Data from P2/3 GALAXI trial (NCT03466411) for Crohn's disease in 2020
(J&J)
-
Jan 22, 2020 -
Key 2020 Events
P2/3 data
http://www.investor.jnj.com/_document/key-events-q1-2020?id=0000016f-cd22-d0cf-a76f-ed6ef78b0000
Jan 22, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious